Chrysamine G

Chrysamine G

SCHEMBL15818024

O=C([O-])c1cc(N=Nc2ccc(-c3ccc(N=Nc4ccc(O)c(C(=O)[O-])c4)cc3)cc2)ccc1O.[Na+].[Na+]

nearest known ligand 0.70

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ABCC8ACEADORA1ADORA2AADORA2BADORA3ALDH5A1ALOX5ALOX5APATP4AATP4BBRAFCA1CA12CA2CA4CYSLTR1DHFRDPEP1EDNRAEDNRBESR2F10FDPSFGF1GABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGARTGNRHRGSC1HMGCRIMPDH1IMPDH2KCNJ11LY96NOD2NR3C1NS3NS4ANS5bP2RY1P2RY12P2RY2P2RY4P2RY6PBP2XPDE3APDE3BPDE4APDE4BPDE4CPDE4DPDK1PDK2PDK3PDK4PPARGPPATPTGIRPTGS1PTGS2RAF1RYR1RYR3SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASERPINC1SLC12A1SLC12A3SYKTHRATHRBTLR3TLR4TLR9TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYMSVKORC1XDHblablaIMP-1blaOXA-33blaOXA-58blaT-3blaT-4blaT-5blaT-6dacAdacBdacCfolAfolPfolP1ftsIfusAgaggyrAgyrBmecAmrcAmrcBmrdApbp1apbp1bpbp2pbp2apbp2bpbp3pbp4pbpApbpBpbpCpbpFpolponBrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpoArpoBrpoCrpoZrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Chrysamine G. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ THRB known ✓ P10828 1/20 0.70
▸ PDE4A known ✓ P27815 1/20 0.58
▸ PTGS1 known ✓ P23219 3/20 0.53
▸ PTGS2 known ✓ P35354 3/20 0.53
▸ ADORA3 known ✓ P0DMS8 1/20 0.42
▸ ADORA2A known ✓ P29274 1/20 0.42
▸ CA1 known ✓ P00915 1/20 0.40
▸ CA2 known ✓ P00918 1/20 0.40
▸ TDP1 Q9NUW8 4/20 0.70
▸ MEN1 O00255 3/20 0.70
▸ KMT2A Q03164 3/20 0.70
▸ APP P05067 1/20 0.70
▸ RECQL P46063 1/20 0.70
▸ BLM P54132 1/20 0.70
▸ BLVRB P30043 2/20 0.58
▸ KDR P35968 1/20 0.58
▸ HTT P42858 1/20 0.58
▸ ALDH1A1 P00352 4/20 0.53
▸ PHLPP2 Q6ZVD8 4/20 0.53
▸ CYP2C9 P11712 2/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Olsalazine SCHEMBL3476110 0.93 MEN1 (0.66) TDP1MEN1KMT2AAPPTHRB
Olsalazine SCHEMBL29454399 0.93 MEN1 (0.66) TDP1MEN1KMT2AAPPTHRB
Olsalazine SCHEMBL29767 0.93 MEN1 (0.66) TDP1MEN1KMT2AAPPTHRB
SCHEMBL29950230 0.88 MEN1 (0.61) TDP1MEN1KMT2AAPPTHRB
SCHEMBL27985065 0.88 MEN1 (0.61) TDP1MEN1KMT2AAPPTHRB
SCHEMBL10784910 0.88 MEN1 (0.59) TDP1MEN1KMT2AAPPTHRB
SCHEMBL1614891 0.87 TDP1 (0.57) TDP1MEN1KMT2AAPPTHRB
Olsalazine SCHEMBL15201080 0.86 MEN1 (0.79) TDP1MEN1KMT2AAPPTHRB
SCHEMBL428681 0.84 PLCG1 (0.61) TDP1MEN1KMT2AAPPTHRB
SCHEMBL135508 0.84 PLCG1 (0.61) TDP1MEN1KMT2AAPPTHRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9808155-B2 Apparatus to detect amyloid in a patient user's retina in a diagnosis, advancement and prognosis of alzheimer's disease, traumatic brain injury, macular degeneration and a plurality of neurodegenerative disorders and ocular diseases NEUROVISION IMAGING LLC (US) 2017-11-07 — — US claimed
US-20140176908-A1 APPARATUS AND METHOD FOR DETECTING AMYLOID IN A RETINA IN A DIAGNOSIS, ADVANCEMENT, AND PROGNOSING OF ALZHEIMER'S DISEASE, TRAUMATIC BRAIN INJURY, MACULAR DEGENERATION AND A PLURALITY OF NEURODEGENERATIVE DISSORDERS AND OCULAR DISEASES WILDCAT PARTNER HOLDINGS, LP 2014-06-26 — — US claimed
US-9808155-B2 Apparatus to detect amyloid in a patient user's retina in a diagnosis, advancement and prognosis of alzheimer's disease, traumatic brain injury, macular degeneration and a plurality of neurodegenerative disorders and ocular diseases NEUROVISION IMAGING LLC (US) 2017-11-07 — — US disclosed
US-20140176908-A1 APPARATUS AND METHOD FOR DETECTING AMYLOID IN A RETINA IN A DIAGNOSIS, ADVANCEMENT, AND PROGNOSING OF ALZHEIMER'S DISEASE, TRAUMATIC BRAIN INJURY, MACULAR DEGENERATION AND A PLURALITY OF NEURODEGENERATIVE DISSORDERS AND OCULAR DISEASES WILDCAT PARTNER HOLDINGS, LP 2014-06-26 — — US disclosed
Send feedback